TIDL PAIN RELIEF MASSAGING ROLL-ON

Manufacturer
The Anthos Group
Effective date
2022-10-26
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 23:51:15

Label at a glance#

ProductTIDL PAIN RELIEF MASSAGING ROLL-ON
Active ingredientMENTHOL, LIDOCAINE
Label structure8 sections

Dosage and administration

Adults and children 12 years of age and older apply a thin layer to affected area every 6-8 hours , not more han 3-4 times daily massage until thoroughly absorbed into skin wash hands with soap and water after each usemore than 3 to 4 times daily Children under 12 years of age : consult a doctor

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Lidocaine 4%,

Menthol 2.5%

OTC - PURPOSE SECTION

Topical anesthetic

INDICATIONS & USAGE SECTION

Use for the temporary relief of pain

WARNINGS SECTION

Wamings
For extemal use only .

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If pregnant or breast-feeding , ask a health professional before use . Keep out of reach of children and pets. If swallowed , get medical help or contact a Poison Control Center right away

INACTIVE INGREDIENT SECTION

Ginger Extract
Saffron Extract
Water
Mugwort Leaf Extract
Vanillyn Butyl
Borneol
Carbohydrates

Directions

DOSAGE & ADMINISTRATION SECTION

Adults and children 12 years of age and older
apply a thin layer to affected area every 6-8 hours , not more han 3-4 times daily
massage until thoroughly absorbed into skin
wash hands with soap and water after each usemore than 3 to 4 times daily
Children under 12 years of age : consult a doctor

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

79740-011-01

79740-010-0179740-010-01

79740-011-02

79740-010-0279740-010-02

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
2619421lidocaine 4 % / menthol 2.5 % Topical SolutionPSN1
2619421lidocaine 40 MG/ML / menthol 25 MG/ML Topical SolutionSCD1
2619421lidocaine 4 % / menthol 2.5 % Topical SolutionSY1

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
LIDOCAINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
79740-011-012024-01-30C16284748780-11030e365-503d-111a-e063-dadaa90a10e279740-011 TIDL PAIN RELIEF MASSAGING ROLL-ON
79740-011-022024-01-30C16284748780-11030e365-503d-111a-e063-dadaa90a10e279740-011 TIDL PAIN RELIEF MASSAGING ROLL-ON

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
79740-011-01TIDL PAIN RELIEF MASSAGING ROLL-ON85 g in 1 BOTTLELINIMENT851
79740-011-02TIDL PAIN RELIEF MASSAGING ROLL-ON85 g in 1 BOTTLELINIMENT851

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
79740-011TIDL PAIN RELIEF MASSAGING ROLL-ON (ROLL-ON) LINIMENT [THE ANTHOS GROUP]1Legacy NDC, 2 package rows20221029_ebe98b71-1f34-4d40-e053-2a95a90a4c02.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
79740-01179740-011-02, 79740-011-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ebe98b71-1f35-4d40-e053-2a95a90a4c02ebe98b71-1f34-4d40-e053-2a95a90a4c022022-10-26WarningsExact identifier
spl id: ebe98b71-1f35-4d40-e053-2a95a90a4c02
spl set id: ebe98b71-1f34-4d40-e053-2a95a90a4c02

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.